Back
Regeneron Pharmaceuticals, Inc. Stock Predictions
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
59
REGN
Regeneron Pharmaceuticals, Inc.
Last Price:
$767.87
Seasonality Move:
12.13%
7 Day Trial
ALL ACCESS PASS
$
7
Regeneron Pharmaceuticals, Inc. Stock Forecast
-
Over the next 52 weeks, Regeneron Pharmaceuticals, Inc. has on average historically risen by 29.2% based on the past 34 years of stock performance.
-
Regeneron Pharmaceuticals, Inc. has risen higher in 20 of those 34 years over the subsequent 52-week period, corresponding to a historical accuracy of 58.82%
-
Is Regeneron Pharmaceuticals, Inc. Stock Undervalued?The current Regeneron Pharmaceuticals, Inc. [REGN] share price is $767.96. The Score for REGN is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
-
REGN is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
Will Regeneron Pharmaceuticals, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Regeneron Pharmaceuticals, Inc. has on average historically risen by 29.2% based on the past 34 years of stock performance.
Regeneron Pharmaceuticals, Inc. Stock Rating
Buy
59
Regeneron Pharmaceuticals, Inc. (REGN)
is a Buy
Is Regeneron Pharmaceuticals, Inc. overpriced?
-
Regeneron Pharmaceuticals, Inc. has risen higher in 20 of those 34 years over the subsequent 52-week period, corresponding to a historical accuracy of 58.82%
Regeneron Pharmaceuticals, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
S&P500
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
regeneron.com
52-Week Data
52-Week High:
790.98
52-Week Low:
476.49
Prediction Charts
Market Cap:
80.7B
Price in USD:
767.96
Volume:
2.3M
Beta:
0.93
Technical Analysis
SMA50:
678.03
SMA100:
625.58
SMA200:
600.91
52-Wk Change:
8.43%
Stock Predictions
-
Is Regeneron Pharmaceuticals, Inc. stock public?Yes, Regeneron Pharmaceuticals, Inc. is a publicly traded company.
-
What is the Regeneron Pharmaceuticals, Inc. stock quote today?The Regeneron Pharmaceuticals, Inc. stock price is 767.96 USD today.
-
How to buy Regeneron Pharmaceuticals, Inc. stock online?You can buy Regeneron Pharmaceuticals, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Dec-2 | 742.12 | 742.00 | 747.00 | 731.00 |
| Dec-3 | 730.36 | 723.67 | 744.23 | 720.07 |
| Dec-4 | 732.45 | 722.80 | 735.00 | 721.22 |
| Dec-5 | 723.00 | 718.36 | 736.15 | 717.26 |
| Dec-8 | 723.69 | 703.26 | 724.13 | 701.75 |
| Dec-9 | 705.11 | 692.58 | 711.15 | 691.86 |
| Dec-10 | 695.06 | 726.21 | 728.00 | 692.50 |
| Dec-11 | 726.08 | 746.80 | 753.61 | 726.08 |
| Dec-12 | 741.59 | 741.29 | 746.05 | 734.38 |
| Dec-15 | 748.85 | 752.62 | 756.67 | 746.38 |
| Dec-16 | 752.57 | 746.36 | 757.35 | 734.72 |
| Dec-17 | 746.55 | 749.79 | 751.99 | 743.33 |
| Dec-18 | 747.54 | 748.71 | 752.84 | 739.23 |
| Dec-19 | 753.72 | 767.96 | 773.85 | 748.18 |
Regeneron Pharmaceuticals, Inc. Earnings
Regeneron Pharmaceuticals, Inc. Earnings Report: Per Share Regeneron Pharmaceuticals, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Regeneron Pharmaceuticals, Inc. Forecast Revenue Growth
Regeneron Pharmaceuticals, Inc. Stock Analysis: Historical quarterly revenues per share for Regeneron Pharmaceuticals, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings decrease this quarter of $3.81 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.74 per share, and an increase next year of $0.97 per share.
* Regeneron Pharmaceuticals, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.